Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech SA    STDM   FR0000053266

SARTORIUS STEDIM BIOTECH SA (STDM)
Mes dernières consult.
Most popular
  Report  
SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201520162017201820192020
Sales8841 0521 0811 1631 2801 440
EBITDA231289295318355406
Operating profit (EBIT)185226222259291365
Pre-Tax Profit (EBT)170213221250278341
Net income139177161184209263
P/E ratio39,031,234,537,933,328,2
EPS ( € )1,511,921,752,022,302,72
Dividend per Share ( € )0,330,420,460,510,590,63
Yield0,56%0,70%0,76%0,66%0,77%0,82%
Reference price ( € )58.959.9760.2976.7576.7576.75
Announcement Date02/01/2016
06:00am
01/30/2017
06:00am
01/31/2018
06:08am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201520162017201820192020
Debt86,459,011014954,1-
Finance-----94,0
Operating income (EBITDA)231289295318355406
Leverage
(Debt/EBITDA)
0,37x0,20x0,37x0,47x0,15x-
Capital Expenditure53,079,712716612496,5
Book Value Per Share (BVPS)6,96 €8,22 €9,46 €11,1 €13,0 €14,7 €
Cash Flow per Share1,52 €1,70 €1,90 €2,65 €2,91 €3,21 €
Announcement Date02/01/2016
06:00am
01/30/2017
06:00am
01/31/2018
06:08am
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 7 108 M€ -
Entreprise Value (EV) 7 257 M€ 7 162 M€
Valuation 2018e 2019e
P/E ratio (Price / EPS) 37,9x 33,3x
Capitalization / Revenue 6,11x 5,56x
EV / Revenue 6,24x 5,60x
EV / EBITDA 22,8x 20,1x
Yield (DPS / Price) 0,66% 0,77%
Price to book (Price / BVPS) 6,91x 5,91x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 22,3% 22,7%
operating Leverage (Delta EBIT / Delta Sales) 2,24x 1,21x
Net Margin (Net Profit / Revenue) 15,8% 16,3%
ROA (Net Profit / Asset) 11,3% 11,9%
ROE (Net Profit / Equities) 18,8% 18,3%
Rate of Dividend 25,2% 25,7%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   14,3% 9,72%
Cash Flow / Sales 21,0% 21,0%
Capital Intensity (Assets / Sales) 1,40x 1,37x
Financial Leverage (Net Debt / EBITDA) 0,47x 0,15x
EPS & Dividend